USG Programs

These figures provide a general overview of U.S. funding for global health.

As Congress considers reauthorizing the President’s Emergency Plan for AIDS Relief (PEPFAR) for a fourth time, a new KFF Policy Watch details key facts about the program and top issues related to its authorization and funding. Created in 2003 as the U.S. government’s signature global health effort in the fight…

This year, Congress will consider reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR). This Policy Watch provides fast facts about the program and top issues related to its authorization and funding.

An outbreak of Ebola is currently ongoing in the Democratic Republic of Congo (DRC), now the second largest Ebola epidemic ever recorded. This Issue Brief gives an overview of the current situation, explains the U.S. role in responding to the outbreak, and answers key questions about the broader global response.

This tracker provides a listing of global health-related legislation introduced in the current Congress.

Blended finance is the subject of increasing attention and growing excitement in global health. Our new brief provides background on this development funding approach, and presents key takeaways from a policy roundtable discussion we held earlier this year.

More than two years into President Trump administration’s promotion of an “America First” approach to international affairs, the April 2019 KFF Health Tracking Poll examines the public’s attitudes toward key global health issues, including views on the U.S. role in world affairs and global health, and support for global health spending.

On Thursday, April 25, the Kaiser Family Foundation and the CSIS Global Health Policy Center held a policy roundtable on the latest data on funding for global health, including from the U.S. government. It began with a brief presentation by Joseph Dieleman of the Institute for Health Metrics and Evaluation…

This brief examines the U.S. government’s efforts in global health security – that is, activities to help countries prepare for and develop capacities to address epidemic and pandemic diseases. The brief provides history and background, outlines the U.S. agencies carrying out these efforts, describes funding, and highlights key policy issues going forward.

This brief looks at one of the key outstanding questions about the potential impact of the expanded Mexico City Policy (or “Protecting Life in Global Health Assistance”): the size of the universe of affected NGOs.